Investor Presentation Q1 2018 Audited Results slide image

Investor Presentation Q1 2018 Audited Results

II Introduction to the Company The Company in numbers 17+ years Experience in pharmaceutical distribution 2nd #1 Growing pharmaceutical distributor in Egypt Largest pharmaceutical distributor with c.19.5% market share' in Q1 2018 c.41k Retail pharmacies, hospitals & wholesalers served in Q1 2018 Over 350 Multinational & local pharmaceutical suppliers, covering over 93% of the market value 5,600+ Employees 56 625 Operational sites in Q1 2018, including distribution hubs and warehouses Distribution vehicles in Q1 2018 EGP 2.9bn Q1 2018 Gross Revenues EGP 92.3mn Q1 2018 EBITDA 31% Gross Revenue CAGR from 2012-2017 50% Net Profit CAGR from 2012-2017 ibnsinapharma (1) Market share covers pharmacy retail sales which represent the majority of Egypt's pharmaceuticals market Source: IMS Health, Company Management IN 4
View entire presentation